Compliance & EnforcementCompliance & Enforcement
ArchiveCompliance & Enforcement
14,067 articles from the Compliance & Enforcement Brief.
Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Court Finds That Qui Tam Relator Cannot Enforce 340B Program Statute
Texas Neurologist Pays $1.8 Million to Resolve FCA, Stark Allegations
Second Circuit Clarifies Anti-Kickback Statute’s Scienter Requirement
New DOJ Whistleblower Program Is Reminder for Companies to Bolster Culture Around Reporting
DOJ’s 2023 False Claims Act Recoveries and Early Trends in 2024
Anticorruption Enforcement and the Foreign Corrupt Practices Act: Trends to Track in 2024
Counterclaims Against Compliance-Officer-Turned-Relator Survive Motion to Dismiss
Federal Highway Administration – Buy America Requirements for Manufactured Products
Federal Judge Orders Whistleblower Who Filed a “Frivolous” Qui Tam to Pay Over $1 Million for Defendants’ Attorneys’ Fees
Gunvor’s Blockbuster FCPA Settlement
Relator’s FCA Claim Against Government Contractor Survives Motion to Dismiss Gauntlet Mostly Intact
Top 10 International Anti-Corruption Developments for February 2024
One of the Largest Medicare Fraud Schemes in History Results in 9-Year Prison Sentence
Former Stericycle Finance Director Indicted on FCPA Charges
Federal Highway Administration – Request for Information on the Use of Manufactured Products in Highway Projects
DOJ Flexes Its Post-Polansky (c)(2)(A) Muscles and Moves To Dismiss Qui Tam Midway Through Discovery
The Gunvor FCPA Enforcement Action
Relator Claimed Defendants Caused Moderna and Pfizer to Make False Claims Under COVID Vaccine Contracts. The Court Wasn’t Persuaded.
FinCEN Issues Final Rule Extending Beneficial Ownership Information Reporting Deadline for New Entities
Keep reading
